sodium nitrite / Hope Pharm - LARVOL DELTA

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite (clinicaltrials.gov) - P2; N=0; Withdrawn; Sponsor: Hope Pharmaceuticals; N=200 ➔ 0; Trial completion date: Dec 2020 ➔ Aug 2020; Recruiting ➔ Withdrawn

Clinical • Enrollment change • Trial completion date • Trial withdrawal • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite (clinicaltrials.gov) - P2; N=200; Recruiting; Sponsor: Hope Pharmaceuticals; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite (clinicaltrials.gov) - P2; N=200; Not yet recruiting; Sponsor: Hope Pharmaceuticals

Clinical • New P2 trial • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases